|
|
2007
|
2008
|
2009
|
2010
|
|
|
|
|
|
|
|
Group revenue, reported (average)
|
11.010
|
11.466
|
12.311
|
12.977
|
|
Group revenue, reported (high)
|
11.135
|
11.667
|
12.610
|
13.523
|
|
Group revenue, reported (low)
|
10.835
|
11.193
|
11.721
|
12.173
|
|
|
|
|
|
|
|
Group revenue excl. one-off items (average)
|
10.658
|
11.467
|
12.371
|
13.285
|
|
Group revenue excl. one-off items (high)
|
10.711
|
11.627
|
12.610
|
13.523
|
|
Group revenue excl. one-off items (low)
|
10.618
|
11.261
|
12.159
|
13.055
|
|
|
|
|
|
|
|
Other pharmaceuticals (average)
|
1.752
|
1.603
|
1.497
|
1.435
|
|
Other pharmaceuticals (high)
|
1.776
|
1.666
|
1.558
|
1.480
|
|
Other pharmaceuticals (low)
|
1.726
|
1.525
|
1.404
|
1.343
|
|
|
|
|
|
|
|
Cipralex (average)
|
4.146
|
4.656
|
5.085
|
5.405
|
|
Cipralex (high)
|
4.171
|
4.779
|
5.307
|
5.639
|
|
Cipralex (low)
|
4.131
|
4.539
|
4.835
|
4.894
|
|
|
|
|
|
|
|
Ebixa (average)
|
1.675
|
1.905
|
2.113
|
2.246
|
|
Ebixa (high)
|
1.686
|
1.974
|
2.214
|
2.323
|
|
Ebixa (low)
|
1.662
|
1.837
|
2.040
|
2.204
|
|
|
|
|
|
|
|
Azilect (average)
|
172
|
232
|
301
|
347
|
|
Azilect (high)
|
177
|
260
|
381
|
495
|
|
Azilect (low)
|
165
|
191
|
231
|
260
|
|
|
|
|
|
|
|
Serdolect (average)
|
39
|
83
|
147
|
208
|
|
Serdolect (high)
|
40
|
119
|
275
|
325
|
|
Serdolect (low)
|
37
|
63
|
84
|
105
|
|
|
|
|
|
|
|
Circadin (average)
|
-
|
36
|
88
|
145
|
|
Circadin (high)
|
-
|
60
|
130
|
203
|
|
Circadin (low)
|
-
|
20
|
48
|
100
|
|
Lexapro - Income from US (average)
|
2.634
|
2.692
|
2.749
|
2.878
|
|
Lexapro - Income from US (high)
|
2.668
|
2.800
|
2.971
|
3.179
|
|
Lexapro - Income from US (low)
|
2.582
|
2.554
|
2.556
|
2.631
|
|
|
|
|
|
|
|
Profit from operations (EBIT), reported (average)
|
3.031
|
2.955
|
3.251
|
3.507
|
|
Profit from operations (EBIT), reported (high)
|
3.158
|
3.096
|
3.440
|
3.842
|
|
Profit from operations (EBIT), reported (low)
|
2.849
|
2.837
|
3.024
|
3.301
|
|
|
|
|
|
|
|
Profit from operations (EBIT), excl. one-off items (average)
|
2.694
|
2.914
|
3.219
|
3.485
|
|
Profit from operations (EBIT), excl. one-off items (high)
|
2.735
|
3.055
|
3.414
|
3.834
|
|
Profit from operations (EBIT), excl. one-off items (low)
|
2.649
|
2.831
|
3.024
|
3.301
|
|
|
|
|
|
|
|
Financial income, net (average)
|
7
|
26
|
42
|
88
|
|
Financial income, net (high)
|
38
|
70
|
76
|
160
|
|
Financial income, net (low)
|
(52)
|
(15)
|
(24)
|
(14)
|
|
|
|
|
|
|
|
Tax on profit (average)
|
29,8%
|
30,0%
|
30,0%
|
30,0%
|
|
Tax on profit (high)
|
30,0%
|
30,0%
|
30,0%
|
30,0%
|
|
Tax on profit (low)
|
29,3%
|
30,0%
|
30,0%
|
30,0%
|
|
|
|
|
|
|
|
Earnings per share (average)
|
10,25
|
10,59
|
11,84
|
13,03
|
|
Earnings per share (high)
|
10,78
|
11,12
|
13,01
|
14,53
|
|
Earnings per share (low)
|
9,47
|
10,18
|
11,05
|
12,19
|
|
